M&A

Once Again, Walgreens May Try To Sell U.K. Boots Pharmacies
Forbes
Mon, 05/13/24 - 10:15 pm
Walgreens
UK
M&A
Boots
Walgreens Boots Alliance
Takeover target? Activist investor believes Novavax tech would be in ‘better hands’ with Big Pharma
Pharma Voice
Thu, 05/9/24 - 11:40 am
Novavax
M&A
vaccines
Pharma has over $500B in capital for deals
Stat
Wed, 05/8/24 - 11:27 am
M&A
Why selling to Novartis made sense for Mariana
BioPharma Dive
Sun, 05/5/24 - 11:37 pm
Novartis
Mariana
M&A
JPMHC 2024
FTC seeks more information on Novo Nordisk parent-Catalent deal
Reuters
Fri, 05/3/24 - 11:28 am
FTC
Novo Nordisk
Catalent
M&A
Novartis further entrenches into radiopharma with $1B Mariana buy
Fierce Biotech
Thu, 05/2/24 - 11:41 am
Novartis
M&A
Mariana Oncology
radiopharmaceuticals
Quest Finds its Path to AI in Cancer Diagnostics Through M&A
Medical Devices and Diagnostics Industry
Wed, 05/1/24 - 11:13 pm
Medtech
Quest Diagnostics
diagnostics
M&A
PathAI Diagnostics
R&D
artificial intelligence
Sweet Harmony: Neuro biotech buys Epygenix and its epilepsy meds for $35M upfront
Fierce Biotech
Tue, 04/30/24 - 06:36 pm
Harmony Biosciencws
Epygenix
M&A
epilepsy
M&A rumor mill is buzzing as Publicis pulls ahead of agency pack
Medical Marketing and Media
Tue, 04/30/24 - 06:28 pm
pharma marketing
M&A
Publicis
Ono swoops on Deciphera in $2.4 billion takeover
Pharmaphorum
Mon, 04/29/24 - 09:54 am
Ono Pharma
Deciphera Pharma
M&A
Labcorp to acquire Invitae’s assets for $239M
Medtech Dive
Thu, 04/25/24 - 05:52 pm
LabCorp
M&A
Invitae
diagnostics
Medtech
Emergence of ADCs as the “hot, new technology”
Pharmaphorum
Thu, 04/25/24 - 11:39 am
antibody-drug conjugate
Immunogen
AbbVie
Seagen
Pfizer
cancer
M&A
Biogen: Don’t expect any big acquisitions this year
BioPharma Dive
Wed, 04/24/24 - 09:31 pm
Biogen
Pharma CEOs
Chris Viehbacher
M&A
Incyte Inks $750M Deal to Buy Escient and Skin Disease Drug Candidates
BioSpace
Tue, 04/23/24 - 09:46 pm
Incyte
M&A
Escient Pharma
atopic dermatitis
Biopharma M&A more than doubled in the first quarter compared to the year prior: report
Fierce Biotech
Thu, 04/18/24 - 11:11 am
M&A
biotech
AstraZeneca
Merck
Gracell
Harpoon Therapeutics
‘We think in decades’: J&J’s $30B spending spree may not be over
Medtech Dive
Tue, 04/16/24 - 10:07 pm
JNJ
Medtech
M&A
Abiomed
Laminar
Shockwave Medical
A two-decade bet on Seagen pays off
Stat
Mon, 04/15/24 - 11:03 am
Pfizer
Seagen
M&A
Merck Paid $208 Million to Stop Its Drugs From Working
Motley Fool
Sun, 04/14/24 - 01:27 pm
Merck
M&A
Abceutics
antibody-drug conjugate
Novartis may have bought MorphoSys, but it really only had eyes for BET inhibitor pelabresib: filing
Fierce Biotech
Fri, 04/12/24 - 11:23 am
Novartis
MorphoSys
pelabresib
myelofibrosis
M&A
BET inhibitor
EU approves Illumina's plan to divest cancer test maker Grail
Reuters
Fri, 04/12/24 - 11:08 am
Europe
Illumina
Grail
M&A
diagnostics
Medtech

Pages